1294P A final analysis of a phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non–small-cell lung cancer: TORG1937 (DATE study)
| Autor: | Kondo, T., Kubota, K., Nakamichi, S., Misumi, T., Murakami, S., Shiraishi, Y., Imai, H., Harada, D., Isobe, K., Itani, H., Takata, S., Wakui, H., Taniguchi, Y., Ikeda, S., Asao, T., Furuya, N., Hosokawa, S., Kobayashi, Y., Takiguchi, Y., Okamoto, H. |
|---|---|
| Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S746-S747 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|